Organigram Global (OGI) Interest & Investment Income (2018 - 2021)
Organigram Global (OGI) posted quarterly Interest & Investment Income of -$432000.0 for Q2 2021, down 1185.35% year-over-year from $39802.9 in Q2 2020, and down 274.9% quarter-over-quarter from $247000.0 in Q1 2021.
Organigram Global (OGI) Interest & Investment Income (2018 - 2021) Analysis & Trends
Organigram Global (OGI) has reported Interest & Investment Income for 4 consecutive years, with -$432000.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Interest & Investment Income fell 1185.35% year-over-year to -$432000.0; the TTM figure through May 2021 stood at -$173002.3 (down 126.03% YoY), while the FY2023 annual figure was $3.0 million, changed N/A from the prior year.
- Interest & Investment Income declined to -$432000.0 in Q2 2021 per OGI's latest filing, from $247000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $872879.5 in Q3 2019 and bottomed at -$578000.0 in Q2 2018.
- Historically, Interest & Investment Income has averaged -$31542.6 across 4 years, with a median of -$74804.8 in 2020.
- On a YoY basis, Interest & Investment Income climbed as much as 252.47% in 2021 and fell as far as 1185.35% in 2021.
- Organigram Global's Interest & Investment Income stood at -$578000.0 in 2018, then soared by 251.02% to $872879.5 in 2019, then plunged by 113.29% to -$116000.0 in 2020, then sank by 272.41% to -$432000.0 in 2021.
- Business Quant data shows OGI's Interest & Investment Income at -$432000.0 in Q2 2021, $247000.0 in Q1 2021, and -$116000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organigram Global | 151.93 Mn | 151.81 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2021 | -432,000.00 |
| Feb 28, 2021 | 247,000.00 |
| Nov 30, 2020 | -116,000.00 |
| Aug 31, 2020 | 127,997.72 |
| May 31, 2020 | -33,609.58 |
| Feb 29, 2020 | -162,000.00 |
| Aug 31, 2019 | 872,879.50 |
| May 31, 2019 | -12,693.45 |
| Feb 28, 2019 | -229,000.00 |
| May 31, 2018 | -578,000.00 |